SCHERING-PLOUGH CLARITIN U.S. FIRST HALF SALES ARE $210 MIL., COMPANY TELLS ANALYSTS; NDAs FOR FARESTON AND CLARITIN ADD ARE PENDING AT FDA
Executive Summary
Schering Labs U.S. sales of the nonsedating antihistamine Claritin were $210 mil. in the first half of 1995, according to materials distributed at the Robert W. Baird & Co. 1995 Healthcare Conference Aug. 9 in Chicago.